From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona’s bioscience industry has grown in recent years and by 2014 state bioscience firms employed just over 24,000 in nearly 1,300 business establishments. Four of the state’s five bioscience subsectors have contributed to its 2 percent overall employment gain since 2012, led by double-digit job growth in medical devices (up 11 percent). State academic institutions accounted for nearly $400 million in bioscience-related R&D expenditures in 2014 and NIH funding to these and other non-academic institutions totaled $150.6 million in 2015. Arizona inventors have had 1,751 patents issued in bioscience-related classes since 2012, primarily in medical and surgical devices but also in drugs and pharmaceuticals, microbiology and genetics, and in biochemistry. The state has seen a strong increase in venture capital invested in bioscience-related companies in recent years. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
Dr. Fariba Donovan, an infectious diseases research scientist at the University of Arizona College of Medicine – Tucson, receives contract to examine how the failure to diagnose Valley fever impacts patient health, costs and `antimicrobial stewardship’ of this respiratory infection endemic to the U.S. Southwest.
Is It Obesity or Lipedema? UA Researcher Receives Grant To Study Genetic Risk Factors: Yann Klimentidis, PhD, a genetic epidemiologist at the University of Arizona Mel and Enid Zuckerman College of Public Health, has received funding to study the genetic risk factors for developing lipedema, a painful and body disfiguring condition affecting an estimated 11 percent […]
From his roots as a fair-haired Minnesota farm boy to climbing the ladder of success in big pharma, to blazing a translational academic research path into life-saving therapies, Charles Arntzen has led one extraordinary life in science.
The ‘topping-off’ ceremony for the new $165 million University of Arizona Health Sciences Innovation Building signals the advancement of team-based health professions education in the United States.